Anzalee Khan

9.7k total citations
186 papers, 3.0k citations indexed

About

Anzalee Khan is a scholar working on Psychiatry and Mental health, Physiology and Surgery. According to data from OpenAlex, Anzalee Khan has authored 186 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Psychiatry and Mental health, 39 papers in Physiology and 37 papers in Surgery. Recurrent topics in Anzalee Khan's work include Schizophrenia research and treatment (42 papers), Lysosomal Storage Disorders Research (34 papers) and Mental Health Research Topics (23 papers). Anzalee Khan is often cited by papers focused on Schizophrenia research and treatment (42 papers), Lysosomal Storage Disorders Research (34 papers) and Mental Health Research Topics (23 papers). Anzalee Khan collaborates with scholars based in United States, Canada and United Kingdom. Anzalee Khan's co-authors include Jean‐Pierre Lindenmayer, Gavin Y. Oudit, Richard B. Thompson, Richard S.E. Keefe, Susan R. McGurk, Philip D. Harvey, Morris Traube, Lisa Hoffman, D. Ian Paterson and Miriam Shanks and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Gastroenterology.

In The Last Decade

Anzalee Khan

175 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anzalee Khan United States 33 1.1k 760 457 426 358 186 3.0k
Pasquale Parisi Italy 39 3.0k 2.8× 504 0.7× 456 1.0× 468 1.1× 623 1.7× 230 4.9k
Astrid Dempfle Germany 31 943 0.9× 376 0.5× 460 1.0× 308 0.7× 503 1.4× 129 3.6k
Antonio Pascotto Italy 36 1.4k 1.4× 497 0.7× 728 1.6× 155 0.4× 503 1.4× 84 3.0k
Verneri Anttila United States 18 514 0.5× 361 0.5× 764 1.7× 178 0.4× 211 0.6× 30 3.2k
Manabu Tashiro Japan 36 601 0.6× 1.1k 1.5× 518 1.1× 227 0.5× 511 1.4× 179 3.9k
Toby Pillinger United Kingdom 23 1.4k 1.3× 530 0.7× 426 0.9× 89 0.2× 260 0.7× 67 3.3k
David W. Morris United States 36 1.0k 1.0× 162 0.2× 332 0.7× 217 0.5× 527 1.5× 74 3.5k
John D. Port United States 32 503 0.5× 452 0.6× 334 0.7× 336 0.8× 778 2.2× 114 3.2k
Rita Moretti Italy 32 829 0.8× 539 0.7× 283 0.6× 177 0.4× 335 0.9× 118 3.2k
Yen‐Wen Chen Taiwan 26 498 0.5× 277 0.4× 376 0.8× 181 0.4× 311 0.9× 132 2.2k

Countries citing papers authored by Anzalee Khan

Since Specialization
Citations

This map shows the geographic impact of Anzalee Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anzalee Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anzalee Khan more than expected).

Fields of papers citing papers by Anzalee Khan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anzalee Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anzalee Khan. The network helps show where Anzalee Khan may publish in the future.

Co-authorship network of co-authors of Anzalee Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Anzalee Khan. A scholar is included among the top collaborators of Anzalee Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anzalee Khan. Anzalee Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lynch, Kristle L., C. Prakash Gyawali, Enrique Coss‐Adame, et al.. (2025). The conundrum of esophagogastric junction outflow obstruction: Answers to key clinical questions. Annals of the New York Academy of Sciences. 1549(1). 5–10. 1 indexed citations
2.
Khan, Anzalee, Dwayne L. Barber, William M. McKillop, et al.. (2025). Lentivirus‐mediated gene therapy for Fabry disease: 5‐year End‐of‐Study results from the Canadian FACTs trial. Clinical and Translational Medicine. 15(1). e70073–e70073. 4 indexed citations
3.
Hughes, Derralynn, Gere Sunder‐Plassmann, Ana Jovanović, et al.. (2024). Renal and multisystem effectiveness of 3.9 years of migalastat in a global real‐world cohort: Results from the followME Fabry Pathfinders registry. Journal of Inherited Metabolic Disease. 48(1). e12771–e12771. 7 indexed citations
4.
Khan, Anzalee, et al.. (2024). Questionnaire for diagnosis and response to therapy in rumination syndrome. Diseases of the Esophagus. 37(6). 1 indexed citations
5.
Khan, Anzalee, et al.. (2024). Manometric esophagogastric junction barrier metrics as predictors of gastroesophageal reflux. Esophagus. 21(3). 397–404. 1 indexed citations
6.
Khan, Anzalee, Nikhil Yegya‐Raman, Sinae Kim, et al.. (2021). Montelukast in hospitalized patients diagnosed with COVID-19. Journal of Asthma. 59(4). 780–786. 52 indexed citations
7.
Savarino, Edoardo, Massimiliano di Pietro, Albert J. Bredenoord, et al.. (2020). Use of the Functional Lumen Imaging Probe in Clinical Esophagology. The American Journal of Gastroenterology. 115(11). 1786–1796. 87 indexed citations
8.
Burt, Lauren A., et al.. (2020). Spectrum of microarchitectural bone disease in inborn errors of metabolism: a cross-sectional, observational study. Orphanet Journal of Rare Diseases. 15(1). 251–251. 7 indexed citations
9.
Khan, Anzalee, et al.. (2020). The psychometric properties of the Self-Evaluation of Negative Symptoms Scale (SNS) in treatment-resistant schizophrenia (TRS). Schizophrenia Research. 224. 159–166. 7 indexed citations
10.
Keefe, Richard S.E., Philip D. Harvey, Anzalee Khan, et al.. (2018). Cognitive Effects of MIN-101 in Patients With Schizophrenia and Negative Symptoms. The Journal of Clinical Psychiatry. 79(3). 25 indexed citations
11.
Ghuloum, Suhaila, Ziyad Mahfoud, Mark Opler, et al.. (2017). Validation of the Five-Factor Model of the Arabic Version of the Positive and Negative Syndrome Scale in Schizophrenia. Psychopathology. 50(3). 211–218. 7 indexed citations
12.
Ness, Seth, Michael G. Aman, Anna J. Esbensen, et al.. (2017). Autism Behavior Inventory: A Novel Tool for Assessing Core and Associated Symptoms of Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology. 27(9). 814–822. 33 indexed citations
13.
Ghuloum, Suhaila, Ziyad Mahfoud, Mark Opler, et al.. (2016). Validation of the Arabic Version of Calgary Depression Scale for Schizophrenia. PLoS ONE. 11(9). e0162304–e0162304. 18 indexed citations
14.
Tarnopolsky, Mark A., Hans Katzberg, Basil J. Petrof, et al.. (2016). Pompe Disease: Diagnosis and Management. Evidence-Based Guidelines from a Canadian Expert Panel. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 43(4). 472–485. 45 indexed citations
15.
16.
Hollander, Zsuzsanna, Darlene Dai, Brendan Putko, et al.. (2015). Gender-Specific Plasma Proteomic Biomarkers in Patients with Anderson–Fabry disease. European Journal of Heart Failure. 17(3). 291–300. 42 indexed citations
17.
Myers, Kenneth A., et al.. (2014). Vibration Therapy Tolerated in Children With Duchenne Muscular Dystrophy: A Pilot Study. Pediatric Neurology. 51(1). 126–129. 14 indexed citations
18.
Yates, Karen E., et al.. (2010). Psychiatric patients with histories of aggression and crime five years after discharge from a cognitive-behavioral program. Journal of Forensic Psychiatry and Psychology. 21(2). 167–188. 24 indexed citations
19.
Khan, Anzalee, Jacqueline M. Bourgeois, & Patrick Mohide. (2008). Agnathia-otocephaly complex in a fetus with maternal use of topical 1% salicylate. Clinical Dysmorphology. 17(1). 75–76. 11 indexed citations
20.
Lindenmayer, Jean‐Pierre & Anzalee Khan. (2004). Pharmacological treatment strategies for schizophrenia. Expert Review of Neurotherapeutics. 4(4). 705–723. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pasquale Parisi Breakdown of academic impact, for papers by Astrid Dempfle Breakdown of academic impact, for papers by Antonio Pascotto Breakdown of academic impact, for papers by Verneri Anttila Breakdown of academic impact, for papers by Manabu Tashiro Breakdown of academic impact, for papers by Toby Pillinger Breakdown of academic impact, for papers by David W. Morris Breakdown of academic impact, for papers by John D. Port Breakdown of academic impact, for papers by Rita Moretti Breakdown of academic impact, for papers by Yen‐Wen Chen
Rankless by CCL
2026